Biedrzycka M, Izdebski R, Hryniewicz W, Gniadkowski M, Zabicka D
Infect Dis Ther. 2025; 14(2):401-419.
PMID: 39757270
PMC: 11829885.
DOI: 10.1007/s40121-024-01097-9.
Rotondo C, Venditti C, Butera O, Dimartino V, Messina F, Properzi M
Antibiotics (Basel). 2024; 13(11).
PMID: 39596739
PMC: 11590914.
DOI: 10.3390/antibiotics13111045.
Turton J, Perry C, McGowan K, Turton J, Hope R
J Med Microbiol. 2024; 73(4).
PMID: 38629482
PMC: 11084618.
DOI: 10.1099/jmm.0.001823.
Macesic N, Dennis A, Hawkey J, Vezina B, Wisniewski J, Cottingham H
Infect Control Hosp Epidemiol. 2024; 45(6):709-716.
PMID: 38344902
PMC: 11102827.
DOI: 10.1017/ice.2024.8.
Fasciana T, Antonelli A, Bianco G, Lombardo D, Codda G, Roscetto E
Front Public Health. 2024; 11:1270924.
PMID: 38186699
PMC: 10771343.
DOI: 10.3389/fpubh.2023.1270924.
Arm race among closely-related carbapenem-resistant Klebsiella pneumoniae clones.
Liu Y, Zhu S, Wei L, Feng Y, Cai L, Dunn S
ISME Commun. 2023; 2(1):76.
PMID: 37938732
PMC: 9723571.
DOI: 10.1038/s43705-022-00163-y.
Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital.
De Vita E, De Angelis L, Arzilli G, Baglivo F, Barnini S, Vecchione A
Pathogens. 2023; 12(9).
PMID: 37764948
PMC: 10535761.
DOI: 10.3390/pathogens12091140.
Infection Prevention Control Strategies of New Delhi Metallo-β-lactamase Producing .
Muresu N, Deiana G, Dettori M, Palmieri A, Masia M, Cossu A
Healthcare (Basel). 2023; 11(18).
PMID: 37761789
PMC: 10530878.
DOI: 10.3390/healthcare11182592.
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area.
Mura M, Longo B, Andreini R, Sbrana F, Ripoli A, Andreoli E
Intern Emerg Med. 2023; 18(8):2261-2269.
PMID: 37698741
DOI: 10.1007/s11739-023-03416-3.
Early Intra-Abdominal Bacterial Infections after Orthotopic Liver Transplantation: A Narrative Review for Clinicians.
Taddei R, Riccardi N, Tiseo G, Galfo V, Biancofiore G
Antibiotics (Basel). 2023; 12(8).
PMID: 37627736
PMC: 10451386.
DOI: 10.3390/antibiotics12081316.
Genomic surveillance of multidrug-resistant in Wales reveals persistent spread of ST307 and adaptive evolution of pOXA-48-like plasmids.
David S, Mentasti M, Sands K, Portal E, Graham L, Watkins J
Microb Genom. 2023; 9(5).
PMID: 37227259
PMC: 10272877.
DOI: 10.1099/mgen.0.001016.
Clonal Spread of Hospital-Acquired NDM-1-Producing and in an Italian Neonatal Surgery Unit: A Retrospective Study.
Agosta M, Bencardino D, Argentieri M, Pansani L, Sisto A, Ciofi Degli Atti M
Antibiotics (Basel). 2023; 12(4).
PMID: 37107005
PMC: 10135170.
DOI: 10.3390/antibiotics12040642.
Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Collected as Part of a Global Surveillance Study, 2018 to 2019.
Estabrook M, Muyldermans A, Sahm D, Pierard D, Stone G, Utt E
Antimicrob Agents Chemother. 2023; 67(5):e0140622.
PMID: 37074173
PMC: 10190273.
DOI: 10.1128/aac.01406-22.
Sensitization of KPC and NDM Klebsiella pneumoniae To Rifampicin by the Human Lactoferrin-Derived Peptide hLF1-11.
Morici P, Rizzato C, Ghelardi E, Rossolini G, Lupetti A
Microbiol Spectr. 2022; 11(1):e0276722.
PMID: 36537823
PMC: 9927577.
DOI: 10.1128/spectrum.02767-22.
Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase.
Sadek M, Saad A, Nordmann P, Poirel L
Antibiotics (Basel). 2022; 11(11).
PMID: 36358134
PMC: 9686471.
DOI: 10.3390/antibiotics11111479.
Nosocomial outbreak by NDM-1-producing highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022.
Coppi M, Antonelli A, Niccolai C, Bartolini A, Bartolini L, Grazzini M
Euro Surveill. 2022; 27(43).
PMID: 36305334
PMC: 9615416.
DOI: 10.2807/1560-7917.ES.2022.27.43.2200795.
Global spread and evolutionary convergence of multidrug-resistant and hypervirulent high-risk clones.
Arcari G, Carattoli A
Pathog Glob Health. 2022; 117(4):328-341.
PMID: 36089853
PMC: 10177687.
DOI: 10.1080/20477724.2022.2121362.
A case-control study of infections caused by producing New Delhi metallo-beta-lactamase-1: Predictors and outcomes.
Rodriguez-Noriega E, Garza-Gonzalez E, Bocanegra-Ibarias P, Paz-Velarde B, Esparza-Ahumada S, Gonzalez-Diaz E
Front Cell Infect Microbiol. 2022; 12:867347.
PMID: 35967868
PMC: 9366880.
DOI: 10.3389/fcimb.2022.867347.
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.
Jean S, Harnod D, Hsueh P
Front Cell Infect Microbiol. 2022; 12:823684.
PMID: 35372099
PMC: 8965008.
DOI: 10.3389/fcimb.2022.823684.
Complicated carbapenem-resistant infections: a treatment pathway analysis in Italian sites.
Durante-Mangoni E, Bertolino L, Mastroianni C, Viale P, Bassetti M, Citton R
Infez Med. 2022; 29(3):434-449.
PMID: 35146349
PMC: 8805488.
DOI: 10.53854/liim-2903-15.